New Delhi: The government has prohibited the use of 18 antibiotics, 18 antivirals and one anti-protozoan for treatment in egg laying birds, milch animals, bees and Cattle, Buffalo, Sheep, Goat and Pigs farm from where intestines are procured, or at any stage of production and processing of Animal Casing in establishment.
“The use of any antimicrobial medicinal product for the purpose of promoting growth or to increase yield shall be prohibited,” the commerce and industry ministry said in separate notifications.
It said that the use of any of the following antimicrobials or group of antimicrobials and antimicrobial medicinal product shall be prohibited for treatment of honey bees, milch animals, egg laying birds and cattle, goat, buffalo, sheep and pigs from where intestines are procured, or at any stage of production and processing of Animal Casing in establishment, or from where they are procured, or at any stage of production and processing.
“The use of any antimicrobial medicinal product for the purpose of promoting growth or to increase yield shall be prohibited,” the commerce and industry ministry said in separate notifications.
It said that the use of any of the following antimicrobials or group of antimicrobials and antimicrobial medicinal product shall be prohibited for treatment of honey bees, milch animals, egg laying birds and cattle, goat, buffalo, sheep and pigs from where intestines are procured, or at any stage of production and processing of Animal Casing in establishment, or from where they are procured, or at any stage of production and processing.
You may also like
Bihar poll gambit: CM Nitish Kumar promises 125 free power units; opposition cries 'copycat'
Operation Midnight Hammer: US strikes destroyed only 1 of 3 Iranian nuclear facilities, says report; 'significant' setback
Ex-Arsenal star shares warning over Liverpool's Diogo Jota grief - 'My brain was not here'
Didn't get any notice from high command or state unit chief, says Maha CLP leader Vijay Wadettiwar
OPPO and Hasselblad extend strategic partnership to co-develop next-gen imaging system